Filing Flows › X4 Pharmaceuticals (XFOR) › How it makes money
How X4 Pharmaceuticals (XFOR) makes money
X4 Pharmaceuticals (XFOR) made $2.8M of revenue in the third quarter 2026 (Q3 2026), +75% from a year earlier.
Drawing the Sankey…
Where each dollar of revenue goes
| Line | Q3 2026 | % of revenue |
|---|---|---|
| Revenue | $2.8M | 100.0% |
| Income tax | $3K | 0.1% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q3 2026 | $2.8M | +75% |
| Q2 2026 | $2.4M | +41% |
| Q1 2026 | $2.5M | +178% |
| Q4 2025 | $30.9M | 21× |
| Q3 2025 | $1.6M | +180% |
| Q2 2025 | $1.7M | +202% |
| Q1 2025 | $900K | — |
From X4 Pharmaceuticals' 10-Q filed Nov 4, 2026 (on EDGAR).
Questions
How does X4 Pharmaceuticals make money?
X4 Pharmaceuticals (XFOR) made $2.8M of revenue in the third quarter 2026 (Q3 2026), +75% from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.